ImplantScan ApS: Financial statements 2025
CVR: 44519453
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ImplantScan ApS (CVR 44519453) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,375,959 and a net result of DKK 264,537 compared with DKK -302,660 the year before. That is an increase of 154.1% compared with the year before. Equity in the 2025 report amounted to DKK 1,877. The solvency ratio was 0.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,375,959
- Profit/Loss
- DKK 264,537
- Equity
- DKK 1,877
- Total Assets
- DKK 1,531,982
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.4 mio. | 265 t. | 2 t. | 1 |
| 2024 | - | 541 t. | -303 t. | -263 t. | 1 |
How creditworthy is ImplantScan ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ImplantScan ApS has published its annual report for 2024. Gross profit came to DKK 541,493, and the net result was DKK -302,660.
About ImplantScan ApS
ImplantScan ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2023. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Philip Edward Essebaggers. The company is owned by Anatomica AB and Implantscan AS. In 2025, the company reported a gross profit of DKK 1,375,959 and a net result of DKK 264,537 compared with DKK -302,660 the year before. Equity in the 2025 report amounted to DKK 1,877.